ALGORAE PHARMACEUTICALS LIMITED (1AI)

---

AI Coverage Rating: Active

ASX AI Signals has generated 5 signal for 1AI during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest 1AI Signals
25/06/2026	SELL
25/05/2026	SELL
24/05/2026	SELL
1AI Share Price
Current Price	$0.013
52 Week High	$0.024
52 Week Low:	$0.005
Trading at (% of 52 Week High)	54.17%

Business Overview

Algorae Pharmaceuticals Limited (ASX: 1AI) is a biotechnology company focused on developing treatments for female sexual health conditions. The company is working on innovative therapies aimed at addressing unmet medical needs in this area. Algorae combines scientific research with clinical development to bring new products to market.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for ALGORAE PHARMACEUTICALS LIMITED is supported by weak price performance at a very low current price, indicating potential liquidity and volatility concerns. Market sentiment and AI-driven signals suggest downside risk, warranting a cautious approach.

Latest  ALGORAE PHARMACEUTICALS LIMITED(1AI)   News